L
LB Pharmaceuticals Inc
NASDAQ:LBRX
LB Pharmaceuticals Inc
NASDAQ:LBRX
Price:
24.81
USD
0.61%
Market Closed
Market Cap:
$627.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
LB Pharmaceuticals Inc
NASDAQ:LBRX
|
US |
|
D
|
DongBang Medical Co Ltd
KOSDAQ:240550
|
KR |
|
C
|
Carraro India Ltd
NSE:CARRARO
|
IN |
|
A
|
Autoliv Inc
SWB:LIV
|
SE |
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
L
|
Luxe Holdings Ltd
JSE:LUX
|
ZA |
|
White Gold Corp.
XTSX:WGO
|
CA |
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
IN |
|
Silver Tiger Metals Inc
XTSX:SLVR
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of LBRX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LBRX
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
LBRX Competitors Multiples
LB Pharmaceuticals Inc Competitors
LB Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
L
|
LB Pharmaceuticals Inc
NASDAQ:LBRX
|
627.7m USD | 0 | 0 | 0 | 0 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.8 | 43.7 | 29.5 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.9 | 7.9 | 10.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
